332 results on '"D’Argenio, David Z."'
Search Results
2. An in-silico modeling approach to separate exogenous and endogenous plasma insulin appearance, with application to inhaled insulin
3. Long-term forecasting of a motor outcome following rehabilitation in chronic stroke via a hierarchical bayesian dynamic model
4. Analysis of Complex Absorption After Multiple Dosing: Application to the Interaction Between the P-glycoprotein Substrate Talinolol and Rifampicin
5. Monoclonal Antibody Pharmacokinetics in Cynomolgus Monkeys Following Subcutaneous Administration: Physiologically Based Model Predictions from Physiochemical Properties
6. Predicting monoclonal antibody pharmacokinetics following subcutaneous administration via whole-body physiologically-based modeling
7. A physiological model of granulopoiesis to predict clinical drug induced neutropenia from in vitro bone marrow studies: with application to a cell cycle inhibitor
8. Predicting Chemotherapy-Induced Neutropenia and Granulocyte Colony–Stimulating Factor Response Using Model-Based In Vitro to Clinical Translation
9. Reply to Scagnolari et al
10. Editorial: Model-informed decision making in the preclinical stages of pharmaceutical research and development
11. Feedback Control Indirect Response Models
12. Chikungunya Virus: In Vitro Response to Combination Therapy With Ribavirin and Interferon Alfa 2a
13. Monoclonal Antibody Pharmacokinetics in Cynomolgus Monkeys Following Subcutaneous Administration: Physiologically Based Model Predictions from Physiochemical Properties
14. Long-Term Forecasting of a Motor Outcome Following Rehabilitation in Chronic Stroke via a Hierarchical Bayesian Model of Motor Learning
15. Regenerative Markov Chain Monte Carlo Methods for Pharmacokinetic/Pharmacodynamic Estimation
16. Control of Uncertain Pharmacodynamic Systems
17. Bayesian Inference in Physiologically-based Pharmacokinetic Modeling: Application to Aniticancer Drug Development
18. Intracellular Metabolism of Lamivudine
19. Physiologically Based Modeling to Predict Monoclonal Antibody Pharmacokinetics in Humans from in vitro Physiochemical Properties
20. Pharmacokinetic Parameter Estimation with Stochastic Dynamic Models
21. Glucagon increases insulin levels by stimulating insulin secretion without effect on insulin clearance in mice
22. FLT3 and CDK4/6 inhibitors: Signaling mechanisms and tumor burden in subcutaneous and orthotopic mouse models of acute myeloid leukemia
23. Feedback Control Indirect Response Models
24. Open‐source maximum a posteriori ‐bayesian dosing AdDS to current therapeutic drug monitoring: Adapting to the era of individualized therapy
25. Integrated Population Pharmacokinetic/Viral Dynamic Modelling of Lopinavir/Ritonavir in HIV-1 Treatment-Naïve Patients
26. Glucagon clearance is regulated by nutritional state: evidence from experimental studies in mice
27. Population pharmacokinetic/pharmacodynamic mixture models via maximum a posteriori estimation
28. Editorial: Model-informed decision making in the preclinical stages of pharmaceutical research and development.
29. Experimental Design for Estimating Integrals by Numerical Quadrature, with Applications to Pharmacokinetic Studies
30. Population-Based Efficacy Modeling of Omalizumab in Patients with Severe Allergic Asthma Inadequately Controlled with Standard Therapy
31. Intracellular-signaling tumor-regression modeling of the pro-apoptotic receptor agonists dulanermin and conatumumab
32. A whole‐body circulatory neutrophil model with application to predicting clinical neutropenia from in vitro studies
33. Characteristics of Passive Solute Transport across Primary Rat Alveolar Epithelial Cell Monolayers
34. Plasma pharmacokinetics and oral bioavailability of the 3,4,5,6-tetrahydrouridine (THU) prodrug, triacetyl-THU (taTHU), in mice
35. Plasma pharmacokinetics and oral bioavailability of 3,4,5,6-tetrahydrouridine, a cytidine deaminase inhibitor, in mice
36. An Analysis of Glucose Effectiveness in Subjects With or Without Type 2 Diabetes via Hierarchical Modeling
37. Biokinetic modeling of nanoparticle interactions with lung alveolar epithelial cells: uptake, intracellular processing, and egress
38. A Note on Population Analysis of Dissolution-Absorption Models Using the Inverse Gaussian Function
39. Supplementary_Methods_NNR_final_resubmit_final – Supplemental material for The Efficiency, Efficacy, and Retention of Task Practice in Chronic Stroke
40. Bortezomib interactions with chemotherapy agents in acute leukemia in vitro
41. Nonlinear random effects mixture models: Maximum likelihood estimation via the EM algorithm
42. Population Pharmacokinetic Modeling of Vancomycin in Thai Patients With Heterogeneous and Unstable Renal Function
43. Physiologically-Based Pharmacokinetics and Molecular Pharmacodynamics of 17-(allylamino)-17-demethoxygeldanamycin and Its Active Metabolite in Tumor-Bearing Mice
44. The Pharmacogenetics of NAT2 Enzyme Maturation in Perinatally HIV Exposed Infants Receiving Isoniazid
45. A local effect of CYP24 inhibition on lung tumor xenograft exposure to 1,25-dihydroxyvitamin D3 is revealed using a novel LC–MS/MS assay
46. Affiliation between the American Society of Pharmacometrics and the Journal of Pharmacokinetics and Pharmacodynamics
47. The Efficiency, Efficacy, and Retention of Task Practice in Chronic Stroke
48. The Efficiency, Efficacy, and Retention of Motor Training in Chronic Stroke
49. Defining the Future of Pharmacometrics: The American Society of Pharmacometrics
50. Bridging Pharmacology and Pathophysiology via Systems Modeling
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.